Cosmetic November 19, 2025

FDA’s Adverse Event Reporting for Cosmetics

OMC Admin

OMC AdminContent Writer

FDA’s Adverse Event Reporting for Cosmetics

Cosmetic ingredients and products are not required to have FDA clearance before being sold in the U.S. The only exception is colour additives, which need to be authorised for their intended purpose (apart from the colouring agents used in coal-tar hair dyes).

Companies and individuals that sell cosmetics have a legal obligation to guarantee the security of their products. The FDA requires trustworthy evidence that shows that a cosmetic product is harmful when used as directed by its label or in the usual or anticipated manner before they take safety measures against it.

Adverse events in Cosmetics

The FDA keeps an eye on cosmetics sold on the market to make sure people may use them safely. When a consumer, manufacturer, or medical practitioner submits an adverse event report (AER), FDA may learn of a safety concern. Any issue that occurs after using a cosmetic product might be considered an adverse event.

The main categories of hair care (including shampoos, conditioners, hair smoothing treatments, and hair dyes) and skin care products are where cosmetic product adverse events are most commonly recorded.

Ready to Streamline Your Regulatory Compliance?

Join hundreds of companies who trust OMC Medical for their regulatory needs. Get expert guidance and ensure compliance across all markets.

Call Now +44 208 066 7260

In addition, rinse-off products are reported more frequently than leave-on ones. Certain products have been the focus of numerous adverse reports in recent years.

The data about the adverse report is sent to CAERS by the FDA’s MedWatch Safety Information and Adverse Event Reporting Program, which serves as the entry point for reports about all products subject to FDA regulation.

These reports are not yet confirmed, and this data is unprocessed. However, they are crucial as it is one of the FDA’s few tools to track any cosmetics-related safety issues.

Care must be used while interpreting the reports. The database can provide the public with some broad information about the types of difficulties if any, that other users have reported encountering if anyone is considering utilising a certain product.

How do FDA take action on these adverse safety reports?

FDA constantly monitors adverse event reports and reviews the relevant scientific literature. The following step is to coordinate an examination of the production facilities with the FDA’s Office of Compliance.

The FDA may send warning letters informing businesses that they have noticed legal infractions based on what they discover during an examination. The FDA work with companies to facilitate the voluntary recalls of products.

They occasionally inform the public about potentially dangerous products, which may motivate businesses to cooperate with the FDA in seeking a resolution.

In addition to placing a product on import alert or detaining it, if it seems hazardous or improperly labelled, the FDA now has the option of collaborating with the Department of Justice to take legal action.

The FDA further maintains a watch out for products distributed as cosmetics that falsely promise to change the body’s structure or function. Such claims are illegal for cosmetics to make.

How should one report an adverse event to the FDA?

FDA encourages consumer and medical professional reports of adverse events that are as detailed as possible, including the name and contact information of the individual who experienced the reaction as well as demographic data, such as age, gender, and ethnicity, to help identify whether any particular groups are disproportionately affected.

They also want details on any medical interventions, their results, and the product believed to be responsible for the adverse event, including its purchase location and intended usage.

Any identifying information about the product, such as the batch and lot numbers, is very crucial in order to find the manufacturer and, if required, to aid in a recall.

The FDA aims to increase the number of reports from health professionals and patients who have encountered an adverse event by making the Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS) database public.

Increased transparency will lead to more thorough reports, making it easier for the FDA to spot warning signs of potential safety issues with the products being regulated.

Anybody can file a complaint about the safety or quality of conventional food, cosmetics, or dietary supplements subject to FDA regulation.

Enjoyed this article?

Share it with your network and help others discover great content.

Related Blogs

Stay updated with the latest regulatory updates and insights

Cosmetic Regulatory Requirements in Finland

November 10, 2025

Cosmetic Regulatory Requirements in Finland
Learn More
Cosmetic Regulatory Requirements in Luxembourg

November 17, 2025

Cosmetic Regulatory Requirements in Luxembourg
Learn More
Cosmetic Regulatory Requirements in Sweden

November 17, 2025

Cosmetic Regulatory Requirements in Sweden
Learn More
LinkedIn Message on LinkedIn WhatsApp Start WhatsApp chat Call Call us